Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure

NCT02292030 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2014-11-17

No results posted yet for this study

Summary

The purpose of this study is to explore the efficacy of low energy cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

Conditions

Interventions

DRUG

HTEA

usually high thoracic epidural anesthesia

Sponsors & Collaborators

  • Harbin Medical University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02292030 on ClinicalTrials.gov